Physician

Seth H Berk, MD

According to 2025 Medicare claims, Seth Berk, MD (NPI: 1326073677) practices hematology/oncology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 08057-3146.

Berk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 93,949 HCPCS/CPT codes, and received $1,262,767 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 725 prescription claims across 120 beneficiaries totaling $2,230,070 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 11 claims. Open Payments data shows 6 records totaling $67. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $836,877 and ending at $1,262,767. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	344	56,836	$836,877
2016	362	67,862	$1,123,458
2017	381	69,190	$1,715,229
2018	330	92,757	$1,378,520
2019	331	61,489	$1,051,041
2020	341	106,182	$1,134,864
2021	354	112,832	$1,412,593
2022	401	72,258	$1,584,919
2023	425	66,532	$1,076,568
2024	391	93,949	$1,262,767

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	78	518	$1,101,984
2016	99	641	$2,212,445
2017	98	761	$2,999,950
2018	93	684	$3,045,717
2019	93	762	$3,009,101
2020	104	790	$3,212,746
2021	124	872	$3,489,658
2022	99	663	$2,919,678
2023	117	670	$2,221,573
2024	120	725	$2,230,070

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	136	$54,001
2016	N/R	32	$13,517
2017	N/R	14	$4,869
2018	N/R	N/R	N/R
2019	N/R	14	$5,116
2020	N/R	11	$3,138
2021	N/R	N/R	N/R
2022	N/R	11	$808
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	163	525	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	196	339	$69
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	45	65	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	100	310	$13
96375	Injection of additional new drug or substance into vein	47	233	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	45	1,278	$673,001
Brukinsa	Zanubrutinib	23	690	$257,479
Calquence	Acalabrutinib Maleate	15	450	$230,660
Lenalidomide	Lenalidomide	14	392	$211,652
Imatinib Mesylate	Imatinib Mesylate	19	810	$132,427

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$67	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Seth H. Berk, MD?

Tedicare shows public-source Medicare data for Seth H. Berk, MD (NPI 1326073677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Seth H. Berk, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Seth H. Berk, MD?

Seth H. Berk, MD is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Seth H. Berk, MD have Open Payments data?

Seth H. Berk, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.